$62.18
+0.590 (+0.96%)
At Close: Jun 03, 2026
Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings
03:00pm, Friday, 19'th Jul 2019
ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat
02:50pm, Wednesday, 17'th Jul 2019
Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.
Why one top exec at this $105 billion drugmaker is 'very disappointed' with Trump
03:10pm, Friday, 12'th Jul 2019
Ruud Dobber, AstraZeneca’s biopharmaceuticals president, weighs in on the Trump administration walking back one change it had been seeking in the drug space.
Sign In
Buy IYH